A major move is in the offing as Corcept Therapeutics Inc (CORT) market cap hits 2.47 billion

SQ

On Monday, Corcept Therapeutics Inc (NASDAQ: CORT) opened higher 4.09% from the last session, before settling in for the closing price of $23.01. Price fluctuations for CORT have ranged from $17.86 to $34.28 over the past 52 weeks.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 12.67%. Company’s average yearly earnings per share was noted 5.93% at the time writing. With a float of $87.87 million, this company’s outstanding shares have now reached $107.83 million.

Corcept Therapeutics Inc (CORT) Insider Activity

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Corcept Therapeutics Inc is 14.75%, while institutional ownership is 77.90%. The most recent insider transaction that took place on Feb 01, was worth 48,400. In this transaction Director of this company sold 2,200 shares at a rate of $22.00, taking the stock ownership to the 0 shares. Before that another transaction happened on Jan 02, when Company’s Director sold 2,200 for $22.11, making the entire transaction worth $48,642. This insider now owns 0 shares in total.

Corcept Therapeutics Inc (CORT) Earnings and Forecasts

Wall Street market experts anticipate that the next fiscal year will bring earnings of 27.38 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 5.93% per share during the next fiscal year.

Corcept Therapeutics Inc (NASDAQ: CORT) Trading Performance Indicators

Check out the current performance indicators for Corcept Therapeutics Inc (CORT). In the past quarter, the stock posted a quick ratio of 3.48. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.49. Likewise, its price to free cash flow for the trailing twelve months is 15.81.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.81, a number that is poised to hit 0.26 in the next quarter and is forecasted to reach 0.91 in one year’s time.

Technical Analysis of Corcept Therapeutics Inc (CORT)

Compared to the last year’s volume of 2.21 million, its volume of 1.13 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 94.28%. Additionally, its Average True Range was 1.11.

During the past 100 days, Corcept Therapeutics Inc’s (CORT) raw stochastic average was set at 24.47%, which indicates a significant decrease from 92.63% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 42.98% in the past 14 days, which was lower than the 71.55% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $25.93, while its 200-day Moving Average is $26.41. Nevertheless, the first resistance level for the watch stands at $24.42 in the near term. At $24.89, the stock is likely to face the second major resistance level. The third major resistance level sits at $25.58. If the price goes on to break the first support level at $23.26, it is likely to go to the next support level at $22.56. Should the price break the second support level, the third support level stands at $22.09.

Corcept Therapeutics Inc (NASDAQ: CORT) Key Stats

There are currently 103,080K shares outstanding in the company with a market cap of 2.47 billion. Presently, the company’s annual sales total 401,860 K according to its annual income of 101,420 K. Last quarter, the company’s sales amounted to 123,600 K and its income totaled 31,380 K.